Abu Dhabi launches operations at its regional vaccine distribution hub
Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the Department of Health – Abu Dhabi, Abu Dhabi Investment Office (ADIO), GSK, AD Ports Group, Etihad Cargo, and KEZAD Group. It is a cornerstone of the UAE's expanding life sciences ecosystem and is designed to improve vaccine access across the region. The hub leverages Abu Dhabi's strategic location, its advanced cold-chain logistics infrastructure, and a regulatory environment that is both agile and supportive of innovation. This hub reflects Abu Dhabi's model of cross-sector collaboration uniting government, biopharma, logistics, and innovation under one ecosystem.
The activation of the hub follows a strategic agreement signed between DoH and GSK during Abu Dhabi Global Healthcare Week in 2024 to establish regional vaccine distribution capabilities in the emirate. Now realized, the facility becomes GSK's first vaccine distribution centre in the Middle East and the fourth worldwide, further solidifying Abu Dhabi's role in supporting regional health security and global supply chain resilience.
The hub's activation also marks one of the first major operational milestones under HELM – Abu Dhabi's Life Science Cluster, which was officially launched in April 2025 during Abu Dhabi Global Health Week. As the emirate's flagship platform to drive life sciences investment, innovation, and global collaboration, HELM brings together government, industry, and academia to strengthen Abu Dhabi's position as a preferred global partner in precision health, pharmaceutical manufacturing, and biopharma logistics. The hub's integration under HELM demonstrates how Abu Dhabi is translating its life sciences vision into operational outcomes that drive regional impact.
H.E Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'The operational launch of Abu Dhabi's regional vaccine hub signals our readiness to serve the region with speed, precision, and reliability. More than a logistics milestone, this reflects our long-term vision to position Abu Dhabi as a trusted partner in global health where innovation and resilience translate into timely access and measurable public health impact. Through this hub, we are making vaccines more accessible to communities across borders and strengthening the UAE's leadership in preventive, future-ready healthcare.'
The facility will manage a portfolio of more than 20 vaccines, including those for paediatric and adult populations, supporting lifelong immunisation strategies across multiple markets. Designed for scalability, the hub can accommodate emerging vaccine technologies and increased regional demand, while maintaining the highest global quality and safety standards.
Boyd Chongphaisal, Vice President and General Manager, GSK Gulf, commented:
'The launch of our vaccine distribution hub in Abu Dhabi represents a shared commitment to health security, innovation, and access. Through our strategic partnership with DoH and local stakeholders, we are combining scientific excellence with operational strength to ensure timely, efficient delivery of vaccines across the region. The integration of this hub under HELM further demonstrates GSK's pioneering stance and alignment with Abu Dhabi's vision for driving impactful outcomes in the life sciences sector on a regional and global scale. This initiative is also a testament to Abu Dhabi's position in the global value chain, strengthening its role in global health and innovation.'
Rafed, the operator of the facility, has deployed advanced cold-chain and smart distribution technologies that preserve vaccine integrity and ensure end-to-end visibility throughout the logistics process. The hub is fully integrated with Etihad Cargo's PharmaLife network, which connects Abu Dhabi to more than 100 international destinations and offers time-sensitive, temperature-controlled freight services tailored for pharmaceutical products.
Mohammad Mustafa Saeed, Chief Executive Officer of Rafed added: 'As a PureHealth company, Rafed is committed to delivering healthcare excellence through world-class pharmaceutical logistics. The launch of this regional vaccine distribution hub is a tangible expression of our strategy to strengthen health systems, improve access, and build resilience across borders. By deploying advanced cold-chain and smart distribution technologies, we are enabling real-time, end-to-end visibility. We remain focused on supporting governments and health partners with confidence and reliability to achieve better health outcomes for communities from Abu Dhabi across the Middle East, Africa, and South Asia.'
The facility is expected to distribute millions of doses annually, shortening delivery timelines across the region and improving the integrity of vaccine supply.
Stanislas Brun, Chief Cargo Officer at Etihad Airways added: 'Etihad Cargo's participation in this initiative reflects our continued investment in healthcare logistics. Our network and specialised PharmaLife product play a critical role in transporting temperature-sensitive vaccines reliably and efficiently across the region. We are proud to support Abu Dhabi's vision of becoming a global leader in life sciences and supply chain excellence.'
The facility's activation significantly strengthens Abu Dhabi's life sciences value chain and supports the UAE's ambition to serve as a global hub for innovation-led, knowledge-based industries. Its operational readiness will help improve vaccine access, reduce delivery lead times, and address public health needs through a more proactive and resilient healthcare model.
Pharmaceutical manufacturers and partners interested in leveraging Abu Dhabi's vaccine logistics capabilities are invited to join HELM and explore opportunities through www.helm.ae. The hub is expected to expand in scale and scope as Abu Dhabi continues to invest in strengthening its global life sciences footprint.
About the Department of Health – Abu Dhabi (DoH):
The Department of Health – Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual.
For further information on DOH, visit https://www.doh.gov.ae/ and follow on X, Instagram, Facebook, LinkedIn and YouTube.
For media inquiries, please contact:
Mariam Al Marzooqi,
msalmarzooqi@doh.gov.ae
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
20 minutes ago
- The National
Ten Palestinians reported dead from hunger in Gaza over past 24 hours
At least 10 people have died from starvation in Gaza over the past 24 hours, health officials said on Wednesday. The deaths take the total to 111 Palestinians − including at least 80 children − killed by hunger since the start of the Israel-Gaza war almost 22 months ago, according to the Gaza Health Ministry. This came as more than 100 aid organisations and human rights groups, including Doctors Without Borders (MSF), Save the Children and Oxfam, warned that ' mass starvation ' was spreading in the Palestinian enclave. The head of the World Health Organisation, Tedros Adhanom Ghebreyesus, said a "large proportion" of the population of Gaza was starving. I don't know what you would call it other than mass starvation - and it's man-made," said t On Tuesday, Dr Mohammed Abu Salmiya, director of Al Shifa Hospital in Gaza city, said 21 children had died from malnutrition and starvation in the previous three days. The plight of Gazans trying to collect aid is worsened by the dangers involved. The UN said this week that since late May, more than 1,000 Palestinians have been killed by the Israeli military while waiting for supplies. On Wednesday, four people were killed by Israeli forces near a distribution point in the central Wadi Gaza area, reported official Palestinian news agency Wafa. Gaza city resident Hassouna Al Badri told The National that hunger is forcing desperate people to risk their lives and gather at aid centres rumoured to be receiving flour shipments. But securing supplies is still not guaranteed. 'I stayed there for hours but I came back home empty-handed,' he said. 'People were pushing each other, they don't care what's around them. Even with gunfire everywhere, people are desperate, they are hungry and have no other options.' Mr Al Badri said he would not take the risk again, despite the dire food situation. On the market, one kilogram of flour costs about 70 shekels ($21). "I can't afford that every two days," he said. "We need a mechanism that guarantees aid reaches the warehouses of international organisations. Otherwise, we'll never get our share.' Israel is facing mounting international pressure over the catastrophic humanitarian situation in Gaza, where more than two million people are facing severe food shortages. It flatly denies blocking the entry of supplies, claiming on Wednesday that aid from 700 lorries is inside Gaza and ready for international agencies to collect and distribute it. The Foreign Ministry also said "close to 4,500 trucks entered Gaza, including flour for bakeries and 2,500 tonnes of baby food and high-calorie special food for children', without specifying the period in which these deliveries took place. However, humanitarian organisations say many warehouses filled with aid are just outside the territory and subject to Israeli entry controls. For warehouses inside Gaza, the NGOs are blocked from accessing and delivering the supplies, they say. Israel has also denied the claims of large-scale starvation, accusing Hamas of looting aid and blocking its distribution. But the UN says Israel's restrictions and rejections of permits are the main reason for mounting stockpiles at border crossings. The UN said on Tuesday that 1,054 people have been killed by Israeli forces while trying to obtain food since late May. It said 766 people were killed while heading to sites run by the US and Israeli-backed Gaza Humanitarian Foundation. The UN and NGOs have refused to be involved in GHF operations, with senior officials describing them as 'death traps'. Gaza city resident Um Mohannad Filfil, 55, had one son killed and another injured while trying to bring home a sack of flour. The mother of six also lost her husband to an air strike earlier in the war. 'After I lost my son, I will never let my other son go again to bring flour,' she said through tears. 'I can't afford the prices of food any more. What should we do? I don't even have a place to stay after losing my home and business. 'I need to take care of my wounded son, I must think about how to feed my family. We need the world to see us, to save us.' The UN's efforts to co-ordinate aid have been curtailed, especially with growing restrictions on the organisation's Palestinian agency UNRWA, which has extensive experience and infrastructure from large-scale distribution work in Gaza since 1948. Abed Al Raheem Nazer, 60, believes the only group that can manage aid distribution is UNRWA. 'Other organisations lack the trust and capacity,' the Gaza city resident said. 'My son tried to reach the trucks, but he couldn't get any flour. The crowds were massive and the area was too dangerous. If things continue like this, I don't know how we will manage to get food.' As the situation worsens, the international community faces growing pressure to act. But for families like Ms Filfil's, any solution may come too late. 'What is happening can't be imagined,' she said. 'This war must end. We need help, real help, before more of us are lost.'
Zawya
2 hours ago
- Zawya
SGH achieves remarkable milestone: Five hospitals granted 5-star rating by Newsweek's Global Hospital Rating
Saudi German Health (SGH), a leading healthcare group in the Middle East and North Africa (MENA) region, has reinforced its industry leadership with five of its hospitals in Saudi Arabia earning five-star ratings in Newsweek's Global Hospital Rating. The hospitals in Riyadh, Makkah, Madinah, Aseer, and Jeddah all received this rating, establishing SGH as the healthcare group with the most five-star-rated hospitals in the region. This latest milestone reinforces SGH's unwavering commitment to providing top-patient-centred healthcare, while upholding high clinical standards and embracing innovative healthcare solutions. It also reflects SGH's ongoing efforts to align with Saudi Arabia's ambitious Vision 2030 goals, which aim to improve quality of life and elevate the Kingdom's healthcare sector to global standards. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, said: 'We are proud to be recognised once again as the healthcare group with the highest number of five-star-rated hospitals in the region. This achievement is a testament to our dedication to clinical excellence, innovation, and exceptional service. It is not the first time we lead the region with such accomplishments — earlier this year, we were also honoured with having the highest number of top-ranked hospitals in the region in Newsweek's World's Best Hospitals 2025 list. These achievements reflect our strong leadership, our proud Saudi identity, and our alignment with Vision 2030's healthcare transformation goals.' These recognitions by Newsweek emphasise SGH's role as a pioneer of healthcare excellence in the Kingdom and the wider region. By consistently meeting the highest international standards and achieving outstanding results, Saudi German Health continues to influence the future of healthcare across Saudi Arabia and beyond.
Zawya
3 hours ago
- Zawya
Takeda appoints Hernán Porcile as Head of the EAMEA region, continuing its legacy of visionary leadership
From his new base in Dubai, a key international gateway, Hernán will steer Takeda's strategic priorities across diverse, fast-growing EAMEA (Eurasia, the Middle East, and Africa) markets Dubai, United Arab Emirates - Takeda, a global, research and development-driven biopharmaceutical leader, has appointed Hernán Porcile as the new Area Head for its Eurasia, Middle East and Africa (EAMEA) region. Formerly General Manager of Takeda Mexico, Hernán Porcile assumed his new role on July 1, 2025, and is now based in Dubai, United Arab Emirates, from where he will lead the company's strategic developments and accelerate growth across the diverse region. Hernán's appointment comes at a pivotal moment as Takeda intensifies its focus on advancing sustainable, value-based healthcare across the region. Building on the company's strong foundation, Hernán will deepen collaboration with key stakeholders, strengthen local systems, and drive innovation through scientific exchange and partnerships, further reinforcing Takeda's long-term commitment to resilient healthcare infrastructure and fostering a lasting impact. ' The EAMEA region's rapidly evolving healthcare landscape presents tremendous opportunities for Takeda, particularly as key markets in the region pursue bold national visions. As a purpose-driven, patient-centric company, we are proud to contribute to these transformative efforts by advancing access to innovative and high-quality healthcare solutions. The region remains a strategic growth priority for Takeda, as we continue to invest in sustainable healthcare solutions and deepen our presence across key markets, ' said Hernán Porcile, Takeda's newly appointed EAMEA Area Head. Hernán joined Takeda in 2009 as Administration and Finance Director in Argentina and has since held several leadership roles, including serving as Head of Takeda Mexico and Colombia. He has also overseen operations across Latin America, covering the Southern Cone, Andean Region, Mexico, and Central America. Throughout his career, he has led key transformation initiatives and strategic projects, with expertise spanning finance, commercial development, and gastroenterology. Notably, he oversaw the successful launch of three critical therapies aimed at improving outcomes for patients with multiple myeloma, hereditary angioedema, and inflammatory bowel disease. Prior to joining Takeda, he spent over 12 years at Schering-Plough. Hernán also serves as Secretary of the Mexican Association of Pharmaceutical Research Industries (AMIIF), where he leads the Clinical Research Commission. He holds a degree in Public Accounting from the University of Morón in Argentina and an MBA in Strategy from the University of Belgrano. With deep expertise in emerging markets and a strong track record of transformational leadership, Hernán is poised to play a pivotal role in advancing Takeda's mission to deliver better health and a brighter future to patients across the Eurasia, Middle East and Africa area. About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.
